首頁 > 市場調查報告書 > 製藥

消化器

全球消化不良藥物市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

市場調查報告書

商品編碼

1421055

全球消化不良藥物市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Dyspepsia Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年01月01日 | 出版商:

Value Market Research | 英文 225 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球消化不良藥物市場需求預計將從 2023 年的 103 億美元達到 2032 年近 164.1 億美元的市場規模，2024-2032 年研究期間CAGR為 5.31%。

消化不良藥物是指用於緩解消化不良症狀的藥物或藥物治療，消化不良是一種常見的消化系統疾病，其特徵是上腹部不適或疼痛。消化不良，通常被稱為消化不良，可表現為腹脹、打嗝、噁心以及餐中或餐後飽腹感等症狀。這些藥物旨在緩解這些症狀並改善整體消化健康。

市場動態

消化不良藥物市場是由消化不良流行的因素所驅動的，消化不良是一種常見的消化系統疾病，其特徵是腹部不適和消化不良等症狀。現代生活方式，包括不規則的飲食習慣和高壓力水平，會導致消化不良症狀的發生，從而推動對緩解藥物的需求。胃食道逆流症和消化性潰瘍等胃腸道疾病往往與消化不良並存，進一步提振了市場。人口老化和飲食習慣的改變促進了全球需求，尤其是老年人的需求。提高意識、改善診斷以及某些藥物的非處方藥供應在推動市場成長方面發揮關鍵作用。藥物開發方面持續的技術進步、對聯合療法的關注以及以患者為中心的醫療保健方法進一步促進了消化不良藥物市場的動態格局。隨著個人尋求針對消化不適的有效藥理學解決方案，市場以創新配方和客製化治療來應對，以滿足不同患者的需求。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球消化不良藥物市場的各個細分市場進行了包容性評估。消化不良藥物產業的成長和趨勢為本研究提供了整體方法。

市場區隔

消化不良藥物市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按指示

功能性消化不良
器質性消化不良

依藥物類型

質子幫浦抑制劑
H-2-受體拮抗劑
制酸劑
抗生素
促動力
抗憂鬱藥

透過藥物治療

品牌化
通用的

按模式

在櫃檯
處方

按配銷通路

零售藥局
醫院藥房
網路藥局

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲消化不良藥物市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。消化不良藥物市場的主要參與者包括武田製藥有限公司、阿斯特捷利康公司、Salix Pharmaceuticals Inc.、雅培實驗室、輝瑞公司、賽諾菲公司、寶潔公司、Haleon plc、ANI Pharmaceuticals Inc.、雷迪博士實驗室有限公司。該部分包含競爭格局的整體視圖，其中包括各種策略發展，例如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 按指標進行的市場吸引力分析
- 按藥物類型分類的市場吸引力分析
- 藥物市場吸引力分析
- 按模式分類的市場吸引力分析
- 按配銷通路分類的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球消化不良藥物市場分析：依適應症分類

按適應症概述
歷史和預測數據
按指標分析
功能性消化不良
器質性消化不良

第 6 章：全球消化不良藥物市場分析：依藥物類型

按藥物類型概述
歷史和預測數據
依藥物類型分析
質子幫浦抑制劑
H-2-受體拮抗劑
制酸劑
抗生素
促動力
抗憂鬱藥

第 7 章：全球消化不良藥物市場分析：依藥物分類

按藥物概述
歷史和預測數據
按藥物分析
品牌化
通用的

第 8 章：全球消化不良藥物市場分析：按模式

按模式概述
歷史和預測數據
按模式分析
在櫃檯
處方

第 9 章：全球消化不良藥物市場分析：按分銷管道

按配銷通路分類的概覽
歷史和預測數據
按配銷通路分析
零售藥局
醫院藥房
網路藥局

第 10 章：全球消化不良藥物市場分析：依地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 11 章：消化不良藥品公司的競爭格局

消化不良藥物市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 12 章：公司簡介

公司股份分析
市場集中度
Takeda Pharmaceutical Company Limited

公司簡介
公司收入
產品
最近的發展

AstraZeneca plc.

公司簡介
公司收入
產品
最近的發展

Salix Pharmaceuticals Inc.

公司簡介
公司收入
產品
最近的發展

Abbott Laboratories

公司簡介
公司收入
產品
最近的發展

Pfizer Inc.

公司簡介
公司收入
產品
最近的發展

Sanofi SA

公司簡介
公司收入
產品
最近的發展

Procter & Gamble

公司簡介
公司收入
產品
最近的發展

Haleon plc

公司簡介
公司收入
產品
最近的發展

ANI Pharmaceuticals Inc.

公司簡介
公司收入
產品
最近的發展

Dr Reddy's Laboratories Ltd.

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112113353

The global demand for Dyspepsia Drugs Market is presumed to reach the market size of nearly USD 16.41 BN by 2032 from USD 10.3 BN in 2023 with a CAGR of 5.31% under the study period 2024 - 2032.

Dyspepsia drugs refer to medications or pharmaceutical treatments used to alleviate the symptoms of dyspepsia, a common digestive disorder characterized by discomfort or pain in the upper abdomen. Dyspepsia, often referred to as indigestion, can manifest with symptoms such as bloating, belching, nausea, and a feeling of fullness during or after meals. These drugs aim to relieve these symptoms and improve overall digestive well-being.

MARKET DYNAMICS

The Dyspepsia drugs market is driven by factors rooted in the prevalence of dyspepsia, a common digestive ailment characterized by symptoms like abdominal discomfort and indigestion. Modern lifestyles, including irregular eating habits and high-stress levels, contribute to the occurrence of dyspeptic symptoms, propelling the demand for drugs offering relief. Gastrointestinal disorders, such as GERD and peptic ulcers, often coexist with dyspepsia, further boosting the market. Aging populations and changing dietary habits contribute to the global demand, particularly among the elderly. Increased awareness, improved diagnostics, and over-the-counter availability of certain medications play pivotal roles in driving market growth. Ongoing technological advancements in drug development, a focus on combination therapies, and a patient-centric approach in healthcare further contribute to the dynamic landscape of the dyspepsia drugs market. As individuals seek effective pharmacological solutions for digestive discomfort, the market responds with innovative formulations and tailored treatments to meet diverse patient needs.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of dyspepsia drugs. The growth and trends of dyspepsia drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the dyspepsia drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Indication

Functional Dyspepsia
Organic Dyspepsia

By Drug Type

Proton Pump Inhibitors
H-2-Receptor Antagonists
Antacids
Antibiotics
Prokinetics
Antidepressants

By Medication

Branded
Generic

By Mode

Over-The-Counter
Prescription

By Distribution Channel

Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Dyspepsia Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Dyspepsia Drugs market include Takeda Pharmaceutical Company Limited, AstraZeneca plc, Salix Pharmaceuticals Inc., Abbott Laboratories, Pfizer Inc., Sanofi SA, Procter & Gamble, Haleon plc, ANI Pharmaceuticals Inc., Dr Reddy's Laboratories Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . DYSPEPSIA DRUGS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Indication
- 3.7.2 Market Attractiveness Analysis By Drug Type
- 3.7.3 Market Attractiveness Analysis By Medication
- 3.7.4 Market Attractiveness Analysis By Mode
- 3.7.5 Market Attractiveness Analysis By Distribution Channel
- 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL DYSPEPSIA DRUGS MARKET ANALYSIS BY INDICATION

5.1 Overview by Indication
5.2 Historical and Forecast Data
5.3 Analysis by Indication
5.4 Functional Dyspepsia Historic and Forecast Sales by Regions
5.5 Organic Dyspepsia Historic and Forecast Sales by Regions

6 . GLOBAL DYSPEPSIA DRUGS MARKET ANALYSIS BY DRUG TYPE

6.1 Overview by Drug Type
6.2 Historical and Forecast Data
6.3 Analysis by Drug Type
6.4 Proton Pump Inhibitors Historic and Forecast Sales by Regions
6.5 H-2-receptor Antagonists Historic and Forecast Sales by Regions
6.6 Antacids Historic and Forecast Sales by Regions
6.7 Antibiotics Historic and Forecast Sales by Regions
6.8 Prokinetics Historic and Forecast Sales by Regions
6.9 Antidepressants Historic and Forecast Sales by Regions

7 . GLOBAL DYSPEPSIA DRUGS MARKET ANALYSIS BY MEDICATION

7.1 Overview by Medication
7.2 Historical and Forecast Data
7.3 Analysis by Medication
7.4 Branded Historic and Forecast Sales by Regions
7.5 Generic Historic and Forecast Sales by Regions

8 . GLOBAL DYSPEPSIA DRUGS MARKET ANALYSIS BY MODE

8.1 Overview by Mode
8.2 Historical and Forecast Data
8.3 Analysis by Mode
8.4 Over-the-counter Historic and Forecast Sales by Regions
8.5 Prescription Historic and Forecast Sales by Regions

9 . GLOBAL DYSPEPSIA DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

9.1 Overview by Distribution Channel
9.2 Historical and Forecast Data
9.3 Analysis by Distribution Channel
9.4 Retail Pharmacies Historic and Forecast Sales by Regions
9.5 Hospital Pharmacies Historic and Forecast Sales by Regions
9.6 Online Pharmacies Historic and Forecast Sales by Regions

10 . GLOBAL DYSPEPSIA DRUGS MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1. Overview, Historic and Forecast Data Sales Analysis
- 10.3.2. North America By Segment Sales Analysis
- 10.3.3. North America By Country Sales Analysis
- 10.3.4. United State Sales Analysis
- 10.3.5. Canada Sales Analysis
- 10.3.6. Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1. Overview, Historic and Forecast Data Sales Analysis
- 10.4.2. Europe by Segment Sales Analysis
- 10.4.3. Europe by Country Sales Analysis
- 10.4.4. United Kingdom Sales Analysis
- 10.4.5. France Sales Analysis
- 10.4.6. Germany Sales Analysis
- 10.4.7. Italy Sales Analysis
- 10.4.8. Russia Sales Analysis
- 10.4.9. Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1. Overview, Historic and Forecast Data Sales Analysis
- 10.5.2. Asia Pacific by Segment Sales Analysis
- 10.5.3. Asia Pacific by Country Sales Analysis
- 10.5.4. China Sales Analysis
- 10.5.5. India Sales Analysis
- 10.5.6. Japan Sales Analysis
- 10.5.7. South Korea Sales Analysis
- 10.5.8. Australia Sales Analysis
- 10.5.9. South East Asia Sales Analysis
- 10.5.10. Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1. Overview, Historic and Forecast Data Sales Analysis
- 10.6.2. Latin America by Segment Sales Analysis
- 10.6.3. Latin America by Country Sales Analysis
- 10.6.4. Brazil Sales Analysis
- 10.6.5. Argentina Sales Analysis
- 10.6.6. Peru Sales Analysis
- 10.6.7. Chile Sales Analysis
- 10.6.8. Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1. Overview, Historic and Forecast Data Sales Analysis
- 10.7.2. Middle East & Africa by Segment Sales Analysis
- 10.7.3. Middle East & Africa by Country Sales Analysis
- 10.7.4. Saudi Arabia Sales Analysis
- 10.7.5. UAE Sales Analysis
- 10.7.6. Israel Sales Analysis
- 10.7.7. South Africa Sales Analysis
- 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE DYSPEPSIA DRUGS COMPANIES

11.1. Dyspepsia Drugs Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12 . COMPANY PROFILES OF DYSPEPSIA DRUGS INDUSTRY

12.1. Company Share Analysis
12.2. Market Concentration Rate
12.3. Takeda Pharmaceutical Company Limited
- 12.3.1. Company Overview
- 12.3.2. Company Revenue
- 12.3.3. Products
- 12.3.4. Recent Developments
12.4. AstraZeneca plc.
- 12.4.1. Company Overview
- 12.4.2. Company Revenue
- 12.4.3. Products
- 12.4.4. Recent Developments
12.5. Salix Pharmaceuticals Inc.
- 12.5.1. Company Overview
- 12.5.2. Company Revenue
- 12.5.3. Products
- 12.5.4. Recent Developments
12.6. Abbott Laboratories
- 12.6.1. Company Overview
- 12.6.2. Company Revenue
- 12.6.3. Products
- 12.6.4. Recent Developments
12.7. Pfizer Inc.
- 12.7.1. Company Overview
- 12.7.2. Company Revenue
- 12.7.3. Products
- 12.7.4. Recent Developments
12.8. Sanofi SA
- 12.8.1. Company Overview
- 12.8.2. Company Revenue
- 12.8.3. Products
- 12.8.4. Recent Developments
12.9. Procter & Gamble
- 12.9.1. Company Overview
- 12.9.2. Company Revenue
- 12.9.3. Products
- 12.9.4. Recent Developments
12.10. Haleon plc
- 12.10.1. Company Overview
- 12.10.2. Company Revenue
- 12.10.3. Products
- 12.10.4. Recent Developments
12.11. ANI Pharmaceuticals Inc.
- 12.11.1. Company Overview
- 12.11.2. Company Revenue
- 12.11.3. Products
- 12.11.4. Recent Developments
12.12. Dr Reddy's Laboratories Ltd.
- 12.12.1. Company Overview
- 12.12.2. Company Revenue
- 12.12.3. Products
- 12.12.4. Recent Developments